Get your health and wellness news from New Jersey
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
Pseudo-journalism: Pink-slime
Press releases
Publish your press release
14 hours ago
ANK Behavioral Health Launches New Website to Enhance Access to Psychiatric Care in New Jersey
EIN Presswire
Mount Laurel, NJ, practice modern telehealth platform featuring psychiatric evaluations, medication management, and evidence-based mental health care for adults MOUNT LAUREL, NJ, UNITED STATES, May 8, 2026 /EINPresswire.com/ -- ANK Behavioral...
May. 7, 2026
New Jersey Air Filtration Company Brookaire Educates on Carbon Pleated Air Filters - Helps Facility Managers and Homeowners Tackle Indoor Air Quality and Odor Problems
GlobeNewswire, Inc.
Fair Lawn, NJ, May 07, 2026 (GLOBE NEWSWIRE) -- Indoor air quality has become a front-and-center concern for building owners, facility managers, and homeowners across the United States.
May. 7, 2026
Cushman & Wakefield and Greystone Close $20.8 Million FHA/HUD Loan for HELIO Apartments Refinance in Kearny, New Jersey
GlobeNewswire, Inc.
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Greystone has provided a $20,766,500 FHA/HUD-insured loan to refinance HELIO Apartments, a newly completed 69-unit multifamily property in Kearny, New Jersey.
May. 6, 2026
Domenic DiPiero Appointed by Governor to New Jersey State Investment Council
EIN Presswire
RED BANK, NJ, UNITED STATES, May 6, 2026 /EINPresswire.com/ -- Domenic DiPiero, President and Founder of Newport Capital Group, has been appointed by the Governor of New Jersey to serve on the New Jersey State Investment Council.
May. 7, 2026
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
GlobeNewswire, Inc.
The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4.1 billion USD, representing...
May. 7, 2026
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
GlobeNewswire, Inc.
As Part of the Settlement, Hetero Labs Ltd. Receives a License to Market Generic FIRDAPSE Beginning in January 2035 Catalyst has No Other FIRDAPSE Patent Litigation Pending CORAL GABLES, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Catalyst...
Video Stories
Discover Affinity Group Publishing
Sign up for:
New Jersey Health Reporter
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
